16
Participants
Start Date
May 31, 2007
Primary Completion Date
July 31, 2008
Study Completion Date
February 28, 2009
Nexavar (Sorafenib, BAY43-9006)
The purpose of this study is to: 1)evaluate how your body reacts to sorafenib when taken daily in combination with paclitaxel and carboplatin, 2) measure your blood levels of sorafenib, paclitaxel and carboplatin at specific times after taking the medication, and 3) to determine the safety of sorafenib.
New Haven
San Antonio
Lead Sponsor
Bayer
INDUSTRY